CoChat
Sign Up
Cited by 19Neurological disorders and treatmentsObsessive-Compulsive Spectrum DisordersTranscranial Magnetic Stimulation Studies

Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation

Open access
Hamani, Clement, Giacobbe, Peter, Diwan, Mustansir, Balbino, Eliane S., Tong, Junchao, Bridgman, Alanna, Lipsman, Nir, Lozano, Andres M. +2 more·2012·American Journal of Psychiatry
DOI 10.1176/appi.ajp.2012.12060754PMC PMC5756069
Open this paper in CoChat — free account

Abstract

To the

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2012.12060754

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A case report suggests augmenting effects of SCC DBS with a monoamine oxidase inhibitor but not with other antidepressants.

    “A casereport suggests augmenting effects of SCC DBS with monoamine oxidase inhibitor but not with other antidepressants [111].”

    From Deep brain stimulation for depression. (2022) · cites this paper as [111]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Hamani, C., Giacobbe, P., Diwan, M., Balbino, E. S., Tong, J., Bridgman, A., Lipsman, N., Lozano, A. M., Kennedy, S. H., & Nobrega, J. N.
Affiliations
Toronto
ORCID
Venue
American Journal of Psychiatry
Publisher
American Psychiatric Association Publishing
Published
2012-12
Volume
169
Issue
12
Pages
1320-1321
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
DOI
10.1176/appi.ajp.2012.12060754
PMC
PMC5756069
OpenAlex
W2111529357
Cited by
19
References
5
Citations by year
2024: 2 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2016: 1 · 2014: 2 · 2013: 1
FWCI
0.63
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • Canadian Institutes of Health Research (110970_1)
Topics
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
monoamine oxidase inhibitors, deep brain stimulation, drug potentiation, antidepressant effects, neuromodulation
MeSH terms
Adult, Antidepressive Agents, Combined Modality Therapy, Depressive Disorder, Humans, Male, Monoamine Oxidase Inhibitors, Tranylcypromine, Treatment Outcome, Deep Brain Stimulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review